Onorati Monica, Nicola Marta, Renda Anna, Lancia Mauro, Di Nuovo Franca
Pathology, ASST Rhodense, Garbagnate Milanese, ITA.
Pathology, G. Salvini Hospital, Garbagnate Milanese, ITA.
Cureus. 2020 May 22;12(5):e8234. doi: 10.7759/cureus.8234.
The iron-deficiency anemia is a common disorder worldwide. It is widely treated with oral iron supplements as ferrous sulfate compound in pill or tablet form, and continuous therapy can induce gastric diseases. The diagnosis of this unusual drug-induced disease is based on the endoscopic findings and the histopathological biopsy examination, because the clinical symptoms are vague and non-specific. Herein we report five cases of iron pill-induced gastritis after oral ferrous sulfate administration. The aim of this report is to underline that iron pill-induced gastritis is an under-diagnosed entity that must be kept in mind when patients undergo chronic iron-pill therapy because it can carry severe upper digestive tract complications. Moreover, we would speculate about the potential tumorigenic role of iron intake in iron-induced gastric inflammation.
缺铁性贫血是一种全球常见的疾病。它广泛采用口服铁补充剂进行治疗,这些补充剂以硫酸亚铁化合物的形式制成药丸或片剂,持续治疗可能会引发胃部疾病。这种不寻常的药物性疾病的诊断基于内镜检查结果和组织病理学活检检查,因为临床症状模糊且不具特异性。在此,我们报告5例口服硫酸亚铁后铁丸所致胃炎的病例。本报告的目的是强调铁丸所致胃炎是一种诊断不足的疾病,在患者接受慢性铁丸治疗时必须予以考虑,因为它可能导致严重的上消化道并发症。此外,我们还将推测铁摄入在铁诱导的胃炎症中潜在的致瘤作用。